Home › Rheumatoid Arthritis › Texas › Mesquite
Rheumatoid Arthritis clinical trials in Mesquite, TX
6 studies for Rheumatoid Arthritis are looking for participants at sites in and around Mesquite (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
RecruitingPhase 1
- Research Site, Mesquite
Phase 1b/2 Study of IV Sarilumab in Adult With RA
RecruitingPhase 1/2
- Southwest Rheumatology Research- Site Number : 8400004, Mesquite
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
RecruitingPhase 2
- Research Site, Mesquite
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RecruitingPhase 2
- Southwest Rheumatology Research /ID# 272268, Mesquite
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Mesquite, Mesquite
ConsideRAte Study - Splenic Stimulation for RA
Recruiting
- Southwest Rheumatology Research, Mesquite
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX12 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Miami, FL8 studies
- Plantation, FL7 studies
- Altoona, PA7 studies
- Dallas, TX7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- San Diego, CA6 studies
- Ann Arbor, MI5 studies
- Chicago, IL5 studies
Other studies in Mesquite
- Obesity9 studies
- Type 2 Diabetes8 studies
- Overweight6 studies
- Lupus4 studies
- COPD4 studies
- Cardiovascular Disease4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.